Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology.
Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection.
Mechanistic basis of zidovudine hypersusceptibility and lamivudine resistance conferred by the deletion of codon 69 in the HIV-1 reverse transcriptase coding region.
Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions.
Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz.
HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions.
Genetic and catalytic efficiency structure of an HCV protease quasispecies.
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
Clinical approach to drug resistance interpretation: expert advice.
Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection.